Cytotoxic, cytoprotective and antioxidant activities of resveratrol and analogues in C6 astroglioma cells in vitro

Chemico-Biological Interactions

Volumn 182, Issue 2-3, 2009, Pages 128-135

  Rüweler, Milena ^a   Gülden, Michael ^a   Maser, Edmund ^a   Murias, Marek ^b   Seibert, Hasso ^a  

^a UNIVERSITY HOSPITAL SCHLESWIG HOLSTEIN   (Germany)

^b POZNAN UNIVERSITY OF MEDICAL SCIENCES   (Poland)

Author keywords

C6 glioma cells; Oxidative stress; Piceatannol; Resveratrol; Resveratrol analogues

Indexed keywords

3,3',4',5,5' PENTAHYDROXYSTILBENE; 3,3',5,5' TETRAHYDROXYSTILBENE; ANTIOXIDANT; CUMENE HYDROPEROXIDE; PICEATANNOL; RESVERATROL; UNCLASSIFIED DRUG;

ANIMAL CELL; ANTIOXIDANT ACTIVITY; ARTICLE; ASTROCYTOMA CELL; CANCER CELL CULTURE; CELL PROLIFERATION; CELL PROTECTION; CONCENTRATION RESPONSE; CONTROLLED STUDY; CYTOTOXICITY; DRUG STRUCTURE; IN VITRO STUDY; NONHUMAN; RAT; STRUCTURE ACTIVITY RELATION;

ANIMALS; ANTINEOPLASTIC AGENTS, PHYTOGENIC; ANTIOXIDANTS; ASTROCYTOMA; CELL LINE, TUMOR; CELL PROLIFERATION; FREE RADICALS; OXIDATIVE STRESS; RATS; REACTIVE OXYGEN SPECIES; STILBENES;

CHANDIPURA VIRUS;

EID: 70350128241     PISSN: 00092797     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cbi.2009.09.003     Document Type: Article

References (34)

1. Aggarwal B.B., Bhardwaj A., Aggarwal R.S., Seeram N.P., Shishodia S., and Takada Y. Role of resveratrol in prevention and therapy of cancer: preclinical and clinical studies. Anticancer Res. 24 (2004) 2783-2840
2. Calabrese V., Cornelius C., Mancuso C., Pennisi G., Calafato S., Bellia F., Bates T.E., Giuffrida Stella A.M., Schapira T., Dinkova Kostova A.T., and Rizzarelli E. Cellular stress response: a novel target for chemoprevention and nutritional neuroprotection in aging, neurodegenerative disorders and longevity. Neurochem. Res. 33 (2008) 2444-2471
3. Knutson M.D., and Leeuwenburgh C. Resveratrol and novel potent activators of SIRT1: effects on aging and age-related diseases. Nutr. Rev. 66 (2008) 591-596
4. Leifert W.R., and Abeywardena M.Y. Cardioprotective actions of grape polyphenols. Nutr. Res. 28 (2008) 729-737
5. Vingtdeux V., Dreses-Werringloer U., Zhao H., Davies P., and Marambaud P. Therapeutic potential of resveratrol in Alzheimer's disease. BMC Neurosci. 9 Suppl. 2 (2008) S6
6. Udenigwe C.C., Ramprasath V.R., Aluko R.E., and Jones P.J. Potential of resveratrol in anticancer and anti-inflammatory therapy. Nutr. Rev. 66 (2008) 445-454
7. Ahmad K.A., Clement M.V., and Pervaiz S. Pro-oxidant activity of low doses of resveratrol inhibits hydrogen peroxide-induced apoptosis. Ann. N.Y. Acad. Sci. 1010 (2003) 365-373
8. de la Lastra C.A., and Villegas I. Resveratrol as an antioxidant and pro-oxidant agent: mechanisms and clinical implications. Biochem. Soc. Trans. 35 (2007) 1156-1160
9. Kundu J.K., and Surh Y.J. Cancer chemopreventive and therapeutic potential of resveratrol: mechanistic perspectives. Cancer Lett. 269 (2008) 243-261
10. Goldberg D.M., Yan J., and Soleas G.J. Absorption of three wine-related polyphenols in three different matrices by healthy subjects. Clin. Biochem. 36 (2003) 79-87
11. Vaz-da-Silva M., Loureiro A.I., Falcao A., Nunes T., Rocha J.F., Fernandes-Lopes C., Soares E., Wright L., Almeida L., and Soares-da-Silva P. Effect of food on the pharmacokinetic profile of trans-resveratrol. Int. J. Clin. Pharmacol. Ther. 46 (2008) 564-570
12. Cai Y.J., Wei Q.Y., Fang J.G., Yang L., Liu Z.L., Wyche J.H., and Han Z. The 3,4-dihydroxyl groups are important for trans-resveratrol analogs to exhibit enhanced antioxidant and apoptotic activities. Anticancer Res. 24 (2004) 999-1002
13. Fauconneau B., Waffo-Teguo P., Huguet F., Barrier L., Decendit A., and Merillon J.M. Comparative study of radical scavenger and antioxidant properties of phenolic compounds from Vitis vinifera cell cultures using in vitro tests. Life Sci. 61 (1997) 2103-2110
14. Lee S.K., Nam K.A., Hoe Y.H., Min H.Y., Kim E.Y., Ko H., Song S., Lee T., and Kim S. Synthesis and evaluation of cytotoxicity of stilbene analogues. Arch. Pharm. Res. 26 (2003) 253-257
15. Murias M., Jager W., Handler N., Erker T., Horvath Z., Szekeres T., Nohl H., and Gille L. Antioxidant, prooxidant and cytotoxic activity of hydroxylated resveratrol analogues: structure-activity relationship. Biochem. Pharmacol. 69 (2005) 903-912
16. Ovesna Z., and Horvathova-Kozics K. Structure-activity relationship of trans-resveratrol and its analogues. Neoplasma 52 (2005) 450-455
17. Ovesna Z., Kozics K., Bader Y., Saiko P., Handler N., Erker T., and Szekeres T. Antioxidant activity of resveratrol, piceatannol and 3,3′,4,4′,5,5′-hexahydroxy-trans-stilbene in three leukemia cell lines. Oncol. Rep. 16 (2006) 617-624
18. Saiko P., Horvath Z., Murias M., Handler N., Jaeger W., Erker T., Fritzer-Szekeres M., and Szekeres T. Antitumor effects of 3,3′,4,4′,5,5′-hexahydroxystilbene in HL-60 human promyelocytic leukemia cells. Nucleosides Nucleotides Nucleic Acids 25 (2006) 1013-1017
19. Queiroz A.N., Gomes B.A.Q., Morales Jr. M.G., and Borges R.S. A theoretical antioxidant pharmacophore for resveratrol. Eur. J. Med. Chem. (2008) 10.1016/j.ejmech.2008.09.023
20. Murias M., Handler N., Erker T., Pleban K., Ecker G., Saiko P., Szekeres T., and Jager W. Resveratrol analogues as selective cyclooxygenase-2 inhibitors: synthesis and structure-activity relationship. Bioorg. Med. Chem. 12 (2004) 5571-5578
21. Benda P., Lightbody J., Sato G., Levine L., and Sweet W. Differentiated rat glial cell strain in tissue culture. Science 161 (1968) 370-371
22. Lowry O.H., Rosenbrough N.J., Farr A.L., and Randall R.J. Protein measurement with the Folin phenol reagent. J. Biol. Chem. 193 (1951) 265-275
23. Linden A., Gülden M., Martin H.J., Maser E., and Seibert H. Peroxide-induced cell death and lipid peroxidation in C6 glioma cells. Toxicol. In Vitro 22 (2008) 1371-1376
24. Rüweler M., Anker A., Gülden M., Maser E., and Seibert H. Inhibition of peroxide-induced radical generation by plant polyphenols in C6 astroglioma cells. Toxicol. In Vitro 22 (2008) 1377-1381
25. Potter G.A., Patterson L.H., Wanogho E., Perry P.J., Butler P.C., Ijaz T., Ruparelia K.C., Lamb J.H., Farmer P.B., Stanley L.A., and Burke M.D. The cancer preventative agent resveratrol is converted to the anticancer agent piceatannol by the cytochrome P450 enzyme CYP1B1. Br. J. Cancer 86 (2002) 774-778
26. Michels G., Watjen W., Weber N., Niering P., Chovolou Y., Kampkotter A., Proksch P., and Kahl R. Resveratrol induces apoptotic cell death in rat H4IIE hepatoma cells but necrosis in C6 glioma cells. Toxicology 225 (2006) 173-182
27. Cohen G. The Fenton reaction. CRC Handbook of Methods for Oxygen Radicals Research (1985), CRC Press., Inc., Boca Raton Fl pp. 55-64
28. Kim H.J., Lee K.W., Kim M.S., and Lee H.J. Piceatannol attenuates hydrogen-peroxide- and peroxynitrite-induced apoptosis of PC12 cells by blocking down-regulation of Bcl-XL and activation of JNK. J. Nutr. Biochem. 19 (2008) 459-466
29. Karlsson J., Emgard M., Brundin P., and Burkitt M.J. trans-Resveratrol protects embryonic mesencephalic cells from tert-butyl hydroperoxide: electron paramagnetic resonance spin trapping evidence for a radical scavenging mechanism. J. Neurochem. 75 (2000) 141-150
30. Kaneuchi M., Sasaki M., Tanaka Y., Yamamoto R., Sakuragi N., and Dahiya R. Resveratrol suppresses growth of Ishikawa cells through down-regulation of EGF. Int. J. Oncol. 23 (2003) 1167-1172
31. Pozo-Guisado E., varez-Barrientos A., Mulero-Navarro S., Santiago-Josefat B., and Fernandez-Salguero P.M. The antiproliferative activity of resveratrol results in apoptosis in MCF-7 but not in MDA-MB-231 human breast cancer cells: cell-specific alteration of the cell cycle. Biochem. Pharmacol. 64 (2002) 1375-1386
32. Lin H.Y., Tang H.Y., Keating T., Wu Y.H., Shih A., Hammond D., Sun M., Hercbergs A., Davis F.B., and Davis P.J. Resveratrol is pro-apoptotic and thyroid hormone is anti-apoptotic in glioma cells: both actions are integrin and ERK mediated. Carcinogenesis 29 (2008) 62-69
33. Zhang W., Fei Z., Zhen H.N., Zhang J.N., and Zhang X. Resveratrol inhibits cell growth and induces apoptosis of rat C6 glioma cells. J. Neurooncol. 81 (2007) 231-240
34. Wolter F., Clausnitzer A., Akoglu B., and Stein J. Piceatannol, a natural analog of resveratrol, inhibits progression through the S phase of the cell cycle in colorectal cancer cell lines. J. Nutr. 132 (2002) 298-302